Callan Family Office’s Northrop Grumman NOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.73M Sell
5,357
-382
-7% -$220K 0.05% 309
2026
Q1
$3.92M Buy
5,739
+121
+2% +$83.7K 0.09% 229
2025
Q4
$3.2M Buy
5,618
+3,078
+121% +$1.79M 0.07% 256
2025
Q3
$1.55M Sell
2,540
-36
-1% -$20.4K 0.05% 307
2025
Q2
$1.29M Buy
2,576
+1,403
+120% +$690K 0.04% 351
2025
Q1
$601K Sell
1,173
-143
-11% -$68.3K 0.05% 291
2024
Q4
$618K Buy
+1,316
New +$662K 0.04% 329

Other funds holding NOC

Callan Family Office's NOC Position: Q2 2026 in Review

Callan Family Office reduced its Northrop Grumman (NOC) stake by 6.7% in Q2 2026, selling an estimated $220K and leaving 5,357 shares worth $2.73M. The position accounts for 0.05% of the portfolio, ranked #309.

Callan Family Office first reported a position in NOC in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.92M in Q1 2026. 1,817 funds tracked by Wall St. Rank hold NOC as of Q2 2026.

  • Callan Family Office held 5,357 shares of Northrop Grumman worth $2.73M as of Q2 2026.
  • Callan Family Office sold 382 Northrop Grumman shares in Q2 2026, an estimated $220K.
  • Northrop Grumman made up 0.05% of Callan Family Office's portfolio in Q2 2026, its #309 holding.
  • Callan Family Office first reported a position in Northrop Grumman in Q4 2024 and has held it in 7 quarters since.
  • Callan Family Office's Northrop Grumman position peaked at $3.92M in Q1 2026.
  • 1,817 funds tracked by Wall St. Rank held Northrop Grumman as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.